LENSAR, Inc.: BRANDES INVESTMENT PARTNERS, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Brandes Investment Partners LP amended its Schedule 13G filing for LENSAR, Inc., updating its beneficial ownership stake with the SEC under accession number 0001015079-26-000101. The amendment signals a change in the investment firm's position in the medical device company, though the filing did not disclose the revised share count or percentage in the headline. Investors will watch for the full filing details to gauge whether Brandes increased or trimmed its LENSAR holdings.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
LENSAR, Inc., BRANDES INVESTMENT PARTNERS, LP